AZmed Secures €15 Million in Series A

by Kay Aloha Villamor in February 21st, 2024

AZmed, a Paris, France-based European MedTech startup, has secured €15 million in Series A funding.  

SaaS Investors  

The round includes investors such as Maison Worms, Techstars, and Teampact Ventures. 

AZmed Use of Funds  

The company will use the funding to accelerate the development of AZmed's AI-driven medical imaging solutions, aiming to streamline radiologists' workflows and enhance patient care. This funding will fuel AZmed's expansion globally, doubling its workforce and intensifying R&D efforts over the next 18 months.  

About AZmed  

AZmed was founded in 2018 with one aim: optimizing physicians' workflow and augmenting them with artificial intelligence. AZmed has developed Rayvolve, an AI software that detects bone lesions on standard radiographs. Rayvolve is a SaaS product and is integrated into the radiologist's workflow. AZmed's CE-marked AI software for fracture detection on X-rays, followed by FDA clearance in 2022, is already deployed in over 1,000 healthcare facilities across 40 countries.  

Funding Details                                       

Company: AZmed  

Raised: €15.0M                       

Round: Series A  

Funding Month: February 2024                                                      

Investors: Maison Worms, Techstars, and Teampact Ventures  

Company Website:  

Software Category: Medical Imaging  


Your cart